Literature DB >> 728423

Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases.

J Travis, J Bowen, R Baugh.   

Abstract

The interaction of human plasma alpha-1-antichymotrypsin with serine proteinases from different tissues has been investigated. The protein was found to form stable complexes with pancreatic chymotrypsin, leukocyte cathepsin G, and mast cell chymotrypsin. No inhibition of pancreatic trypsin or leukocyte elastase could be demonstrated. With mixtures containing both alpha-1-antichymotrypsin and alpha-1-proteinase inhibitor, it was found that the former preferentially inactivated leukocyte cathepsin G, while the latter showed a strong preference for pancreatic chymotrypsin. However, leukocyte elastase was specifically inactivated by alpha-1-proteinase inhibitor even in 1:1 mixtures with chymotrypsin. All of these results taken together suggest that one of the primary functions of alpha-1-antichymotrypsin is to inactivate leukocyte cathepsin G, while alpha-1-proteinase inhibitor controls the activity of other serine proteinases, particularly leukocyte elastase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728423     DOI: 10.1021/bi00619a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

3.  Cathepsin G binding to human platelets. Evidence for a specific receptor.

Authors:  M A Selak; J B Smith
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

4.  Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.

Authors:  D H Perlmutter; J Travis; P I Punsal
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

5.  Cloning of the human alpha 1 antichymotrypsin gene and genetic analysis of the gene in relation to alpha 1 antitrypsin deficiency.

Authors:  G D Kelsey; D Abeliovich; C J McMahon; D Whitehouse; G Corney; S Povey; D A Hopkinson; J Wolfe; G Mieli-Vergani; A P Mowat
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

6.  Hypochlorous acid (HOCl) activation of neutrophil collagenase requires cathepsin G.

Authors:  C Capodici; R A Berg
Journal:  Agents Actions       Date:  1989-06

7.  Cathepsin G and thrombin: evidence for two different platelet receptors.

Authors:  M A Selak
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

8.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

9.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

10.  Alpha-1-antichymotrypsin variant detected by PCR-single strand conformation polymorphism (PCR-SSCP) and direct sequencing.

Authors:  M Tsuda; Y Sei; M Matsumoto; H Kamiguchi; M Yamamoto; Y Shinohara; T Igarashi; M Yamamura
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.